Cefoselis sulfate
Cat.No:IC1850 Solarbio
CAS:122841-12-7
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Anti-Infection >
Anti-Bacterial >
Cefoselis sulfateCAS:122841-12-7
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 122841-12-7 |
Name | Cefoselis sulfate |
Molecular Formula | C19H24N8O10S3 |
Molecular Weight | 620.64 |
Solubility | Soluble in Water/DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 1533716-785-6 |
MDL | MFCD00864819 |
SMILES | O=C(C(N12)=C(CN3N(CCO)C(C=C3)=N)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O.O=S(O)(O)=O |
Target Point | Bacterial |
Passage | Anti-infection |
Background | Cefoselis sulfate is a beta-lactam antibiotic. |
Biological Activity | Cefoselis is a widely used beta-lactam antibiotic. [1] |
In Vitro | Cefoselis had strong antibacterial activity against β-lactamases(ESBLs+AmpC)non-producers(46.1%)of Enterobacteriaceae,and good antibacterial activity against the clinical isolates producing AmpC alone(11.2%).However,cefoselis showed poor activity against ESBLs producing clinical isolates(42.7%).Its activity against Pseudomonas aeruginosa and Acinetobacter lwoffi was moderate.The activity was poor for Acinetobacter baumannii.Cefoselis showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis.Cefoselis was highly active against MSSA and MSCNS,and showed potent antibacterial activity against all penicillin-susceptible Streptococcus pneumoniae(PSSP)and other Streptococcus spp.Its activity was slightly lower for penicillin-intermediate Streptococcus pneumoniae(PISP).[2] |
In Vivo | Cefoselis was dose-dependently appeared in brain extracellular fluid in proportion to its blood level. The elimination constant from brain extracellular fluid(apparent)was slightly lower than that from blood. These results indicated that cefoselis might penetrate the BBB or be discharged by a certain transport system.[1] In renal dysfunction rats,the elimination half-lives of cefoselis from both blood and brain were extensively prolonged. [1] |
Data Literature Source | [1]. K Ohtaki,et al. Cefoselis,a beta-lactam antibiotic,easily penetrates the blood-brain barrier and causes seizure independently by glutamate release. J Neural Transm (Vienna). 2004 Dec;111(12):1523-35. [2]. ZHU,D.,et al.,In vitro activities of cefoselis compared to β-lactams and other antibacterial agents aganst gram-positive and gram-negative clinical isolates. Chinese Journal of Infection and Chemotherapy,2011. 4: p. 002. |
Unit | Bottle |
Specification | 5mg 25mg 50mg |
Cefoselis硫酸盐是β-内酰胺抗生素。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.